Arthritis Research & Therapy

official impact factor 4.36

Open Access Research article

Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis

Kathrin Schwager, Manuela Kaspar, Frank Bootz, Roberto Marcolongo, Erberto Paresce, Dario Neri* and Eveline Trachsel

Arthritis Research & Therapy 2009, 11:R142 doi:10.1186/ar2814


See related editorial by van de Loo and van den Berg, http://arthritis-research.com/content/11/6/132

No comments have yet been made on this article.

Post a comment